FDA Inspection 1293602 — Alfasigma S.p.A.

Alfasigma S.p.A. — FEI 3002808171

The FDA completed an inspection of Alfasigma S.p.A. on January 26, 2024 in Pomezia. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pomezia (Italy)

Additional Details

Mutual Recognition Agreement (MRA)